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CASE REPORT
Placental site trophoblastic tumor 
and choriocarcinoma: an unusual presentation
Abdulrahim Gari*
Abstract 
Background: Mixed trophoblastic tumor composed of choriocarcinoma and placental site trophoblastic tumor was 
diagnosed on histopathology slides review, is a very rare mixed tumor and cured after adjuvant chemotherapy.
Case presentation: Twenty-nine years old, Para 2 female presented with 4 months history of irregular vaginal bleed-
ing after an uncomplicated vaginal delivery. Abdominal examination showed 14 weeks uterus with β-hCG level of 
14,889 mIU/ml. Slides review confirmed the diagnosis of placental site trophoblastic tumor (PSTT). Patient underwent 
total abdominal hysterectomy and resection of anterior vaginal wall mass. Post operative (48 h) β-hCG level was 6016 
mIU/ml. Final pathology showed mixed trophoblastic tumor composed of choriocarcinoma (CC) and PSTT. Adjuvant 
chemotherapy started and continued for three cycles after achieving normal β-hCG.
Conclusion: PSTT is a rare disease and potentially curable. Differential diagnosis in women presented with vaginal 
bleeding and a uterine mass in the post partum period must include gestational trophoblastic disease.
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Background
A rare form of gestational trophoblastic disease (GTD) is 
placental site trophoblastic tumor (PSTT). It arises from 
invasive intermediate gestational trophoblasts and con-
stitutes 1–2  % of all gestational trophoblastic neoplasia 
(GTN) [1]. It was considered a benign lesion before 1981 
when Scully and Young recognized that it was poten-
tially malignant [2]. Approximately 200 cases have been 
reported in the literature [3]. The incidence of GTN var-
ies in different regions from 0.6 to 1.1/1000 pregnancies in 
Europe and North America, while 2/1000 pregnancies in 
Japan and 1/160 pregnancies in India and Middle East [4].
Here we present a rare case of mixed trophoblastic 
tumor consisting of choriocarcinoma (CC) and PSTT. It 
was diagnosed after term normal delivery and managed 
with surgery followed by adjuvant chemotherapy.
The case presentation
A 29  years old female, Para 2 presented with irregular 
vaginal bleeding started 4 months after an uncomplicated 
vaginal delivery of a term male infant. Her first delivery 
was also normal without any antenatal or postnatal com-
plication. Otherwise her history was unremarkable. In 
referring hospital she was diagnosed as a case of retained 
product of conception on ultrasound. Serum beta human 
chorionic gonadotrophin (β-hCG) level was 4253 mIU/
ml. Dilatation and curettage (D&C) done. Final pathology 
showed PSTT.
She was referred on January 28, 2013 for assessment 
and management to our Oncology centre at King Abdul-
lah Medical City, Makkah, Saudi Arabia. On examina-
tion, a thin lean lady was markedly pale with tachycardia. 
Abdominal examination showed 14 week palpable uterus. 
Local examination showed mild bleeding, healthy exter-
nal genitalia, and healthy cervix/vagina. At that time 
β-HCG was 14,889 mIU/ml. Her Hemoglobin (Hb) was 
7.3 and she received four units of packed red blood cells 
(RBCs). Review of slides showed a neoplasm composed 
of proliferation of polyhedral mononuclear intermediate 
trophoblasts with extensive deposition of fibrinoid mate-
rial confirming the diagnosis of PSTT.
Metastatic workup with CT scan of chest, abdomen, 
and pelvis done on February 2, 2013 showed innumer-
able pulmonary nodules scattered in both lungs, largest 
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8.4 mm in right middle lobe. Seven centimeter (cm) het-
erogenous mass filled the endometrial canal and extend-
ing to the level of cervix. The parametria were slightly 
hazy but no definite involvement was found with prom-
inent both adenexa. No evidence of ascites nor lym-
phadenopathy (pelvic, abdominal, inguinal). All other 
structures were within normal limits.
Patient offered surgery (total abdominal hysterectomy) 
followed by chemotherapy but she refused treatment and 
left the hospital against medical advice. Four weeks later, 
she presented to emergency department with heavy vagi-
nal bleeding. Hemoglobin was 6.6  mg/dl and received 
four units of packed RBCs. Abdominal examination 
showed 22  week sized uterus. A newly developed ante-
rior vaginal wall mass of 4 × 4 cm was found. CT scan 
repeated CAP showed interval worsening of pulmonary 
nodules and enlarged uterus with anterior vaginal mass.
Patient agreed for surgery, underwent total abdominal 
hysterectomy and excision of anterior vaginal mass on 
March 3, 2013. Intra operatively uterus was found to be 
enlarged (20 weeks sized) with multiple areas of impend-
ing tumor perforation. Both tubes and ovaries were 
normal with no ascities or any intra-abdominal bleed-
ing. Post-operative course was unremarkable. Repeated 
β-hCG (48  h post-op) was 6016 mIU/ml. The micro-
scopic examination of uterus showed mixed trophoblas-
tic tumor composed of chroriocarcinma (CC) and PSTT. 
Invasion of myometrium, and lymph-vascular inva-
sion were identified. The CC component showed typi-
cal dimorphic picture consisting of syncytiotrophoblasts 
and cytotrophoblasts. Immunohistochemical staining 
for β-hCG revealed positive staining in this component. 
The PSTT which constitute about 20 % of tumor showed 
sheets of monomorphic intermediate trophoblasts and 
fibrinoid material. These cells were strongly positive for 
human placental lactogen (hPL), and inhibin, and nega-
tive for β-hCG, and P-63. Ki-67 proliferation index was 
high in CC component. (Figs. 1, 2).
Three weeks post surgery, combination chemo-
therapy EMA/CO protocol was started and contin-
ued 3 cycle after achieving normal β-hCG (quantitative 
β-hCG <4 mIU/ml). CT scan of the chest showed com-
plete resolution of pulmonary metastasis. Currently she 
is in remission and under monthly follow up.
Discussion
PSTT is rare disease among the other variants of GTN, 
i.e., choriocarcinoma (CC) the most common and epi-
thelioid trophoblastic tumor (ETT) that is also relatively 
rare [5]. It is an extravillous infiltrating tumor, which can 
invade the myometrium and arises from intermediate 
trophoblasts [6].
PSTT produces significantly lower serum levels of hPL 
and serum β-hCG than does CC. On the other hand 
some cases of PSTT with high serum β-hCG have been 
also reported. PSTT may complicate or follow a normal 
term pregnancy, abortion or molar pregnancy. It can pre-
sent months or years after a term gestation with a variety 
of clinical features like; irregular vaginal bleeding, amen-
orrhea, nephrotic syndrome, and rarely, polycythemia or 
virilization. It is usually confined to the uterus at the time 
of diagnosis, but on later stage it has high risk of metas-
tasis to the lungs and vagina [1]. It is less chemo sensitive 
unlike other forms of GTD and produces a lesser amount 
of β-hCG. As a result, surgery is the core treatment but 
adjuvant chemotherapy is increasingly being offered in 
cases of metastasis and large tumor volume [2, 7]. GTD 
has two established risk factors, i.e., reproductive age 
(<20 and >40 years) and previous molar pregnancy. One 
case of Epithelioid Trophoblastic Tumour (ETT) and CC 
has been reported in Australia in 2013 [8]. Our case has 
no such risk factors, and up to our knowledge no such a 
case of PSTT and CC has been reported in literature yet.
Conclusion
PSTT is a rare disease and potentially curable. Differential 
diagnosis in women presented with vaginal bleeding and 
a uterine mass in the post partum period must include 
GTD. Gold standards for diagnostic evaluation of GTD 
is β-hCG and tissue diagnosis. For patients with disease 
localized to the uterus, surgery remains the mainstay of 
therapy in the first instance, in contrast to other GTDs, 
because of it is low chemosensitivity. EMA/CO chemo-
therapy should be considered for metastatic cases.
Consent
Written informed consent was obtained from the patient 
for publication of this Case report and any accompany-
ing images. A copy of the written consent is available for 
review by the Editor of this journal.Fig. 1 Uterus with multiple areas of impending tumor perforation 
with resected anterior vaginal mass
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Fig. 2 a Hematoxylin and eosin (H & E) stain showing dimorphic picture of syncythiotrophoblast and cytotrophoblast in Choriocarcinoma; b 
β-Human Chorionic Gonadotrophin immunohistochemical stain showing positive staining in Choriocarcinoma componants; c H & E Stain showing 
sheets of monomorphic intermediate trophoblasts and fibrinoid material in placental site trophoblastic tumor; d Immunohistochemistry (IHC): hPL 
immunostain showing positive staining in intermediate trophoblasts of placental site trophoblastic tumor; e IHC: Inhibin immunostain showing 
positive staining in intermediate trophoblasts of placental site trophoblastic tumor; f IHC: β-HCG immunostain showing negative staining in inter-
mediate trophoblasts of placental site trophoblastic tumor
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